Liver transplantation for non-hepatocellular carcinoma malignancies

Gregory J. Gores; Julie K. Heimbach; Charles B. Rosen

doi:10.1002/lt.22145

Liver transplantation for non-hepatocellular carcinoma malignancies

Gregory J. Gores, Julie K. Heimbach, Charles B. Rosen

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD.

Original language	English (US)
Pages (from-to)	S22-S25
Journal	Liver Transplantation
Volume	16
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1002/lt.22145
State	Published - Oct 2010

ASJC Scopus subject areas

Surgery
Hepatology
Transplantation

Access to Document

10.1002/lt.22145

Cite this

@article{5a00bfa5db644b16ad1c5fd80f5f31fa,

title = "Liver transplantation for non-hepatocellular carcinoma malignancies",

abstract = "Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD.",

author = "Gores, {Gregory J.} and Heimbach, {Julie K.} and Rosen, {Charles B.}",

year = "2010",

month = oct,

doi = "10.1002/lt.22145",

language = "English (US)",

volume = "16",

pages = "S22--S25",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Liver transplantation for non-hepatocellular carcinoma malignancies

AU - Gores, Gregory J.

AU - Heimbach, Julie K.

AU - Rosen, Charles B.

PY - 2010/10

Y1 - 2010/10

N2 - Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD.

AB - Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti-vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence-based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22-S25, 2010. copy; 2009 AASLD.

UR - http://www.scopus.com/inward/record.url?scp=78651408565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651408565&partnerID=8YFLogxK

U2 - 10.1002/lt.22145

DO - 10.1002/lt.22145

M3 - Article

AN - SCOPUS:78651408565

SN - 1527-6465

VL - 16

SP - S22-S25

JO - Liver Transplantation

JF - Liver Transplantation

IS - SUPPL. 2

ER -

Liver transplantation for non-hepatocellular carcinoma malignancies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this